language_icon
EN
HI

Invicta Diagnostic Share price

INVICTA

78

2.85 (-3.53%)
Last updated on 23 Apr, 2026 | 15:29 IST
Today's High

81.00

Today's Low

78.00

52 Week Low

58.10

52 Week High

105.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Invicta Diagnostic Chart

Invicta Diagnostic Share Key Metrics

Volume
4800.00
Market Cap
101.64 CR
LTQ@LTP
1600@78.00
ATP
79.66
Var Margin
53.5 %
Circuit Range
64.7-97
Delivery %
85.71 %
Value
3.82 L
ASM/GSM
No
Market Lot
1600

Summary

Invicta Diagnostic share price stands at ₹78 at 23 Apr, 2026 | 15:29. The stock Invicta Diagnostic intraday movement has stayed between ₹78.00 and ₹81.00, while on a 52-week basis it has fluctuated from ₹58.10 to ₹105.00.
In terms of trading activity, Invicta Diagnostic has recorded a volume of 4800 shares. The Invicta Diagnostic has a market cap of ₹12571973. The stock’s Average Traded Price (ATP) stands at ₹7966, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1600, 7800.
The Invicta Diagnostic operates within a circuit range of ₹64.7-97 – ₹64.7-97, with a Value of ₹3.82 L. The Delivery Percentage for the day is 85.71%. Additionally, Invicta Diagnostic currently falls under the No framework, and trades with a market lot size of 1600.

Invicta Diagnostic Fundamentals

View More
P/E Ratio

20.78

P/B Ratio

5.41

Div. Yield

0

Sector P/E

54.04

Sector P/B

-16.13

Sec. Div. Yield

2.25

Invicta Diagnostic Resistance and Support

Pivot 79.87

Resistance

First Resistance

82.24

Second Resistance

83.62

Third Resistance

85.99

Support

First Support

78.49

Second Support

76.12

Third Support

74.74

Invicta Diagnostic Shareholding Pattern

View More
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

66.7%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

4.2%

Domestic Institutional Investors

4.3%

Retail

24.81%

Others

-0.01%

Total Promoters
MAR '26
66.7%

Invicta Diagnostic Corporate Actions

DateAgenda
2026-03-25Others

Invicta Diagnostic News

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic held an EGM on April 17, 2026, where all 16 resolutions were approved. Key items included the regularization of Director Rohit Prakash Srivastava and various related party transactions.
Apr 18 2026 18:04:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic announced Rohit Prakash Srivastava's redesignation to Whole Time Director Finance. This formalizes his key leadership role for a five-year term, effective April 17, 2026, leveraging his 19 years of experience.
Apr 17 2026 21:04:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic's EGM on April 17, 2026, approved 15 material related party transactions and changes to IPO proceeds utilization and extension of time limit. This includes regularizing Mr. Rohit Prakash Srivastava as Whole-Time Director (Finance) for a 5-year tenure with ₹7.20 Lakh annual remuneration.
Apr 17 2026 20:04:00

Invicta Diagnostic Limited

Invicta Diagnostic Limited to acquire up to 95% equity stake in Vinchurkar Diagnostics Private Limited for ₹7.60 Cr. This strategic acquisition expands Invicta's diagnostic network into Nashik, strengthening its regional footprint beyond Mumbai Metropolitan Region.
Apr 11 2026 19:04:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic will execute Share Purchase and Shareholders’ Agreement for acquiring up to 95% shareholding of Vinchurkar Diagnostics Private Limited for ₹760 lakhs. This acquisition will be completed in two tranches, with the first 51% by May 31, 2026, and the remaining 44% by October 31, 2026, expanding its diagnostic services.
Apr 11 2026 13:04:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic Ltd board approved the acquisition of Vinchurkar Diagnostics Private Limited for ₹7.60 crores, acquiring up to 95% shareholding. This expands the company's diagnostic services in Nashik, with the target reporting ₹4.45 crores turnover in FY25.
Apr 11 2026 12:04:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic modified terms for acquiring up to 95% stake in Vinchurkar Diagnostics Private Limited for ₹760 lakhs. The second tranche for 44% will now be completed within 9 months of the first tranche and funded by IPO proceeds.
Mar 25 2026 18:03:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic will convene an EGM on April 17, 2026, to approve 14 related party transactions with an annual value of ₹20 crores each over three years. The meeting will also consider changing the utilization of IPO proceeds and regularizing Mr. Rohit Prakash Srivastava as Whole-Time Director.
Mar 25 2026 17:03:00

Invicta Diagnostic Limited

Invicta Diagnostic will hold an Extra-Ordinary General Meeting on April 17, 2026. Key agenda items include the regularization of a director, approval of numerous material related party transactions up to ₹2000 lakhs per year each for the next three fiscal years, and a significant reallocation of ₹2,111.33 lakhs from IPO proceeds for new diagnostic centers and the acquisition of Vinchurkar Diagnostics Private Limited.
Mar 25 2026 17:03:00

Invicta Diagnostic Limited (INVICTA)

Invicta Diagnostic board approved the appointment of Mr. Rohit Prakash Srivastava as Additional Director and Whole-Time Director-Finance. The board also approved material related party transactions and changes in IPO fund utilization, reallocating ₹7.60 crores for the acquisition of Vinchurkar Diagnostics Private Limited to expand its diagnostic network.
Mar 25 2026 12:03:00
Read More

About Invicta Diagnostic

NSE : 760139  
BSE : 0  
ISIN : INE0XJ501010  

Our Company was incorporated as Limited Liability Partnership under the name “Invicta Diagnostic LLP” under the provisions of the Limited Liability Partnership Act 2008 vide Certificate of Incorporation dated January 22 2021 issued by Assistant Registrar of Companies Central Registration Centre. Further Invicta Diagnostic LLP was converted into a private limited company “Invicta Diagnostic Private Limited” pursuant to the provisions of Chapter XXI of the Companies Act 2013 and a fresh Certificate of Incorporation dated December 01 2023 was issued by Assistant Registrar of Companies Central Registration Centre. Subsequently our Company was converted from a private limited company to a public limited company pursuant to a resolution passed in the extraordinary general meeting of our Shareholders held on April 20 2024 and the name of our Company was changed to “Invicta Diagnostic Limited” and a fresh certificate of incorporation dated July 02 2024 was issued to our Company by the Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies Central Processing Centre. The Corporate Identification Number of our Company is U86100MH2023PLC414723.Major Events and Milestones:2021- Incorporation of Erstwhile LLP- Setting up of 1st fully integrated Diagnostic Centre in Thane having the entire gamut of services under its umbrella including PET CT scans CT scans MRI Scans Sonography X-Ray and Pathology2023- Conversion of Erstwhile LLP into a private limited company “Invicta Diagnostic Private Limited” pursuant to the provisions of Chapter XXI of the Companies Act 2013- Acquisition of majority shareholding in “PCD Diagnostics LLP” for a full-fledged diagnostic centre in Marol Andheri East forming it our subsidiary- Acquisition of majority shareholding in “Primacare Healthcare LLP” for a full-fledged diagnostic centre in Byculla forming it our subsidiary- Acquisition of majority shareholding in “Pratham MRI and CT Scan Centre” for a full-fledged diagnostic centre in Bhayandar forming it our subsidiary2024- Acquisition of a diagnostic centre in Sewri from PCD Medical LLP- Acquisition of a diagnostic centre in Parel from Primacare Diagnostic LLP- Acquisition of a centralised laboratory in Parel from Porteus Path Lab LLP- Formation of our subsidiary “Invicta Medical LLP” for setting up of diagnostic centre in KalwaThane- Conversion from Private Limited to Public Limited Company2025- Acquisition of “Porteus Medical LLP” (Formerly known as “Porteus Porteus Path Lab LLP”) for forming it our subsidiary- Acquisition of “Primacare Diagnostic LLP” for setting up of diagnostic centre in Dadar Mumbai forming it our subsidiary- Acquisition of “MSCRIBEIT Infotech LLP” (Formerly Knowns as “PCD Medical LLP”) forming it our Associate

Read More

Invicta Diagnostic Management

NamePosition
Ketan Jayantilal JainNon Executive Director
Sanket Vinod JainChairman
View More

Invicta Diagnostic Similar Stocks

Invicta Diagnostic FAQs

The Buying Price of Invicta Diagnostic share is 78 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Invicta Diagnostic stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Invicta Diagnostic, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Invicta Diagnostic shares is 20.78. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Invicta Diagnostic shares is 5.41. Useful to assess the stock's value relative to its book value.

To assess Invicta Diagnostic’s valuation compare Sector P/E, P/B which are 54.04 & -16.13 with sector averages, along with growth rates and financial metrics.

The Market Cap of Invicta Diagnostic is 101.64 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Invicta Diagnostic share price is 105.00 & 58.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Invicta Diagnostic belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost